Magnesium and congestive heart failure

  • Ye Wen-qiu
  • Chen Shan-wan


The aspect of Mg++ metabolism was studied in 83 patients with congestive heart failure (CHF). The result indicated that CHF per se and treatment with digoxin were not the causes of Mg++ depletion. Pronounced diuresis induced by diuretics increased markedly renal excretion of Mg++ and, in consequence, lowered the plasma Mg++ in 55% of the patients. The hypomagnesemia was not associated with decreased RBC Mg++, and was usually transient and asymptomatic. When in addition to diuretics there were other factors known to promote extra Mg++ loss, the hypomagnesemia became more severe, the RBC Mg++ level might be decreased in association with it. A part of these patients might develop symptomatic Mg++ deficiency, the chief clinical manifestations of which included changes in neuromuscular excitability, mental disturbances and cardiac arrhythmia, often accompanied by hypopotassemia, hypocalcemia and metabolic alkalosis. The important role played by the Mg++ depletion in causing relevant symptoms and other electrolyte disturbances might be identified by careful analysis of the whole situation of the patient and the therapeutic test with Mg++. The lowering of the plasma and RBC Mg++ levels, the decrease in the 24 h urinary Mg++ excretion could be used as routine laboratory diagnostic criteria of Mg++ deficiency, and the application of the Mg++ loading test as an important diagnostic procedure and at the same time a therapeutic test should be used more frequently in the future.

Key words

magnesium congestive heart failure symptomatic magnesium deficiency 

Magnesium und herzdekompensation


  1. 1.
    Iseri LT, et al. Water and electrolyte content of cardiac and skeletal muscle in heart failure and myocardial infarction. Am Heart J 1952;43:215–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Seller RH, et al. Serum and erythrocytic magnesium levels in congestive heart failure: Effect of hydrochlorothiazide. Am J Cardiol 1966;17: 786–91.CrossRefGoogle Scholar
  3. 3.
    Lim P, Jacob E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure. Br Med J 1972; 3:620–2.PubMedCrossRefGoogle Scholar
  4. 4.
    I. 1982;3(1): 1–11.Google Scholar
  5. 5.
    Iseri LT, et al. Magnesium deficiency and cardiac disorders. Am J Med 1975;58:837–46.PubMedCrossRefGoogle Scholar
  6. 6.
    Shanker A, et al. Effects of Furosemide on Serum and Urinary Magnesium in Congestive Heart Failure. In Cantin M, Seelig MS, eds. Magnesium in Health and Disease, Proceedings of the Second International Symposium on Magnesium, New York; Intern Med Pub, 1980;597–604.Google Scholar
  7. 7.
    Prasad AS. Trace Elements and Iron in Human Metabolism. New York and London; Plenum, 1978;159–89.Google Scholar
  8. 8.
    Nordin BEC. Calcium, Phosphate and Magnesium Metabolism. Edinburgh, London and New York; Churchill Livingstone, 1976.Google Scholar
  9. 9.
    Yun TK, et al. The turnover of magnesium in control subjects and in patients with idiopathic cardiomyopathy and congestive heart failure studied with magnesium-28. J Nucl Med 1966;7:177–87.PubMedGoogle Scholar
  10. 10.
    Burch GE, Giles TD. The importance of magnesium deficiency in cardiovascular disease. Am Heart J 1977; 94:649–57.PubMedCrossRefGoogle Scholar
  11. 11.
    Krasner BS. Cardiac effects of magnesium with special reference to anesthesia. A review, Can Anaesth Soc J 1979; 26:181–5.Google Scholar
  12. 12.
    Shils ME. Experimental human magnesium depletion. Medicine 1969;48:61–85.PubMedCrossRefGoogle Scholar

Copyright information

© Wuhan Medical College 1985

Authors and Affiliations

  • Ye Wen-qiu
    • 1
  • Chen Shan-wan
    • 2
  1. 1.Department of Internal MedicineLiaoning Provincial People’s HospitalShenyang
  2. 2.Department of Internal MedicineHospital of Zunyi Medical CollegeZunyi

Personalised recommendations